Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis Article

Full Text via DOI: 10.1053/j.gastro.2018.04.009 PMID: 29655837 Web of Science: 000440023400038
Highly Cited Paper

Cited authors

  • Lee, Brian P.; Mehta, Neil; Platt, Laura; Gurakar, Ahmet; Rice, John P.; Lucey, Michael R.; Im, Gene Y.; Therapondos, George; Han, Hyosun; Victor, David W.; Fix, Oren K.; Dinges, Lisanne; Dronamraju, Deepti; Hsu, Christine; Voigt, Michael D.; Rinella, Mary E.; Maddur, Haripriya; Eswaran, Sheila; Hause, Jessica; Foley, David; Ghobrial, R. Mark; Dodge, Jennifer L.; Li, Zhiping; Terrault, Norah A.

Abstract

  • BACKGROUND & AIMS: The American Consortium of Early Liver Transplantation for Alcoholic Hepatitis comprises 12 centers from 8 United Network for Organ Sharing regions studying early liver transplantation (LT) (without mandated period of sobriety) for patients with severe alcoholic hepatitis (AH). We analyzed the outcomes of these patients. METHODS: We performed a retrospective study of consecutive patients with a diagnosis of severe AH and no prior diagnosis of liver disease or episodes of AH, who underwent LT before 6 months of abstinence from 2006 through 2017 at 12 centers. We collected data on baseline characteristics, psychosocial profiles, level of alcohol consumption before LT, disease course and treatment, and outcomes of LT. The interval of alcohol abstinence was defined as the time between last drink and the date of LT. The primary outcomes were survival and alcohol use after LT, defined as slip or sustained. RESULTS: Among 147 patients with AH who received liver transplants, the median duration of abstinence before LT was 55 days; 54% received corticosteroids for AH and the patients had a median Lille score of 0.82 and a median Sodium Model for End-Stage Liver Disease score of 39. Cumulative patient survival percentages after LT were 94% at 1 year (95% confidence interval [CI], 89%-97%) and 84% at 3 years (95% CI, 75%-90%). Following hospital discharge after LT, 72% were abstinent, 18% had slips, and 11% had sustained alcohol use. The cumulative incidence of any alcohol use was 25% at 1 year (95% CI, 18%-34%) and 34% at 3 years (95% CI, 25%-44%) after LT. The cumulative incidence of sustained alcohol use was 10% at 1 year (95% CI, 6%-18%) and 17% at 3 years (95% CI, 10%-27%) after LT. In multivariable analysis, only younger age was associated with alcohol following LT (P = .01). Sustained alcohol use after LT was associated with increased risk of death (hazard ratio, 4.59; P = .01). CONCLUSIONS: In a retrospective analysis of 147 patients who underwent early LT (before 6 months of abstinence) for severe AH, we found that most patients survive for 1 year (94%) and 3 years (84%), similar to patients receiving liver transplants for other indications. Sustained alcohol use after LT was infrequent but associated with increased mortality. Our findings support the selective use of LT as a treatment for severe AH. Prospective studies are needed to optimize selection criteria, management of patients after LT, and long-term outcomes.

Authors

Publication date

  • 2018

Published in

International Standard Serial Number (ISSN)

  • 0016-5085

Start page

  • 422

Volume

  • 155

Issue

  • 2